This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA

Dr. Qiuheng Jin
R&D Director at Vazyme Biotech
Speaker

Profile

Dr. Qiuheng Jin is an R&D director of the Biomedicine Department, Vazyme Biotech. Since joining the company in 2020, he has successfully led the establishment of mRNA CMC platform. Based on extensive exploration and optimization of mRNA manufacturing processes and quality control methods, he has pioneered the development of cutting-edge enzyme raw materials and analysis techniques, resulting in application of 10 invention patents and publication of 2 peer-reviewed articles. Qiuheng Jin obtained his Ph.D. degree at Zhejiang University. His main research areas were structural biology of transmembrane proteins and anti-viral innate immunity and published 7 high-level articles.

Agenda Sessions

  • Innovation in Assays and Enzymes of RNA Therapeutics Development

    7:45am